The glutamine-deprivation therapy by L-glutaminase that hydrolyzes L-glutamine to L-glutamic acid and ammonia, selectively inhibits tumor growth by the blocking of de novo protein synthesis and increase of the superoxide level by oxidative stress that promotes the death of the cancer cells [7,14,15]. This evidence concerns the gene GLS2 and cancer.